2 weeks Ago By Defense World Staff
Saratoga Research & Investment Management decreased its position in The Procter & Gamble Company ( NYSE:PG – Free Report ) by 3.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 176,607 shares of the company’s stock after selling 5,413 shares during the quarter.
Procter & Gamble accounts for approximately 1.3% of Saratoga Research & Investment Management’s holdings, making the stock its 26th largest position. Saratoga Research & Investment Management’s holdings in Procter & Gamble were worth $29,126,000 at the end of the most recent quarter.
Other institutional investors have also made changes to their positions in the company. Legal & General Group Plc boosted its holdings in Procter & Gamble by 0.6% in the second quarter.
Legal & General Group Plc now owns 21,632,054 shares of the company’s stock worth $3,567,556,000 after purchasing an additional 122,190 shares during the period. Fisher Asset Management LLC raised its stake in Procter & Gamble by 5.5% during the fourth quarter.
Fisher Asset Management LLC now owns 10,552,081 shares of the company’s stock worth $1,546,302,000 after acquiring an additional 554,451 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Procter & Gamble by 8.2% during the second quarter.
Dimensional Fund Advisors LP now owns 9,691,925 shares of the company’s stock valued at $1,598,510,000 after purchasing an additional 733,440 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd.
lifted its holdings in shares of Procter & Gamble by 9.7% in the 1st quarter. Mitsubishi UFJ Asset Management Co.
Ltd. now owns 6,161,507 shares of the company’s stock worth $999,705,000 after purchasing an additional 545,601 shares during the last quarter. Finally, Janus Henderson Group PLC increased its position in Procter & Gamble by 1.
3% in the first quarter. Janus Henderson Group PLC now owns 6,008,938 shares of the company’s stock worth $974,914,000 after buying an additional 79,665 shares during the period. 65.
77% of the stock is currently owned by institutional investors. Insider Buying and Selling In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.
90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now directly owns 11,537 shares in the company, valued at $1,902,451.
30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink . In other news, CEO Jon R.
Moeller sold 37,240 shares of the company’s stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.
60. Following the completion of the transaction, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93.
The sale was disclosed in a filing with the SEC, which can be accessed through this link . Also, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $164.
90, for a total transaction of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.
30. The disclosure for this sale can be found here . Insiders have sold 375,553 shares of company stock worth $63,829,141 in the last quarter.
0.17% of the stock is currently owned by company insiders. Procter & Gamble Stock Up 0.
2 % Procter & Gamble ( NYSE:PG – Get Free Report ) last released its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.
37 by $0.03. The company had revenue of $20.
53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.
46% and a net margin of 17.71%. The firm’s revenue was down .
1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.37 EPS.
Sell-side analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year. Procter & Gamble Dividend Announcement The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th.
Investors of record on Friday, July 19th were paid a $1.0065 dividend. The ex-dividend date was Friday, July 19th.
This represents a $4.03 dividend on an annualized basis and a yield of 2.32%.
Procter & Gamble’s payout ratio is presently 65.85%. Analyst Upgrades and Downgrades Several analysts have weighed in on the company.
Royal Bank of Canada lifted their target price on Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 31st.
Deutsche Bank Aktiengesellschaft raised their target price on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th.
JPMorgan Chase & Co. boosted their price target on shares of Procter & Gamble from $179.00 to $186.
00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Evercore ISI raised their price objective on shares of Procter & Gamble from $177.00 to $183.
00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Finally, Piper Sandler assumed coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.
00 target price on the stock. Eight investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.
com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $175.89. View Our Latest Report on PG About Procter & Gamble ( Free Report ) The Procter & Gamble Company provides branded consumer packaged goods worldwide.
It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands. Read More Five stocks we like better than Procter & Gamble Do Real Estate Investment Trusts Deserve a Place in Your Portfolio? Watch These 3 Former Short-Squeeze Stocks for a Big Rally How is Compound Interest Calculated? Simon Property REIT: A Safe Bet for Growth and Steady Dividends 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion CarMax’s Impressive Rally: What Investors Should Watch Next Want to see what other hedge funds are holding PG? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for The Procter & Gamble Company ( NYSE:PG – Free Report ). Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter .
.
